Resource Re-Allocation During the COVID-19 Pandemic in a Suburban Hospital System: Implications for Outpatient Hip and Knee Arthroplasty by Meneghini, R. Michael
Resource Re-Allocation During the COVID-19 Pandemic in a Suburban Hospital System: 
Implications for Outpatient Hip and Knee Arthroplasty 
R. Michael Meneghini MD
Indiana University Hip and Knee Center 
Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN, 
Indiana University Health Physicians, Indianapolis, IN 
Corresponding Author: 
R. Michael Meneghini, MD
Indiana University Health Hip & Knee Center
Indiana University School of Medicine, Department of Orthopaedic Surgery
13100 East 136th Street, Suite 2000
Fishers, IN 46037
Phone: 317-688-5980
Email: rmeneghi@iuhealth.org
____________________________________________________
This is the author's manuscript of the article published in final edited form as: 
Meneghini, R. M. (2020). Resource Re-Allocation During the COVID-19 Pandemic in a Suburban Hospital System: 
Implications for Outpatient Hip and Knee Arthroplasty. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2020.04.051
Resource Re-Allocation During the COVID-19 Pandemic in a Suburban Hospital System: 1 
Implications for Outpatient Hip and Knee Arthroplasty 2 
 3 
ABSTRACT 4 
The COVID pandemic of 2020 has emerged as a global threat to patients, healthcare providers 5 
and to the global economy.  Due to this particular novel and highly infectious strain of 6 
coronavirus, the rapid community spread and clinical severity of the subsequent respiratory 7 
syndrome created a substantial strain on hospitals and healthcare systems around the world.  The 8 
rapid surge of patients presenting over a small time period for emergent clinical care, admission 9 
to the hospital and intensive care units with many requiring mechanically assisted ventilators for 10 
respiratory support demonstrated the potential to overwhelm healthcare workers, hospitals and 11 
healthcare systems.  The purpose of our article is to describe an effective system for re-12 
deployment of healthcare supplies, resources and personnel to hospitals within a suburban 13 
academic hospital system to optimize the care of COVID patients, while treating orthopaedic 14 
patients in an equally ideal setting to maximize their surgical and clinical care.  This article will 15 
provide a particular focus on the current and future role of a specialty hip and knee hospital and 16 
its partnering ambulatory surgery center in the context of an outpatient arthroplasty program.   17 
 18 
INTRODUCTION 19 
The COVID pandemic is the result of the spread of the SARS-CoV-2 virus, which results in 20 
severe acute respiratory syndrome and in the most severe cases, death.  Its origin is in Wuhan, 21 
People's Republic of China, with the first cases reported there in December of 2019 and has 22 
rapidly spread worldwide since that time.  In March 2020, the World Health Organization 23 
declared COVID-19 a world pandemic and to date, over two million people worldwide have 24 
been infected with the SARS-CoV-2 virus and it will continue to spread throughout the world 25 
over the coming months to years.  Its health and economic consequences have been profound and 26 
have affected nearly all countries across the globe.[1] 27 
 28 
Due to emerging information and epidemiologic modelling leading up to its rapid spread here in 29 
the United States, many institutions were able to prepare and enact a coordinated response in 30 
anticipation of what has been termed the “COVID-19 surge,” and the anticipated shortage of 31 
personal protection equipment, (“PPE”), intensive care unit beds and respiratory ventilators.  32 
This article will discuss how a suburban hospital region within a large academic health system 33 
was able to cohort COVID patients in hospitals with optimal capability and expertise to care for 34 
those patients with severe respiratory illness, while utilizing a smaller orthopedic focused 35 
hospital, Indiana University Hip and Knee Center at Saxony Hospital, to treat the urgent 36 
orthopedic cases.   This article will discuss the successful resource re-allocation methodology 37 
with a particular emphasis on the outpatient and ambulatory setting.   38 
 39 
COVID-19 SURGE ANTICIPATION 40 
Indiana University (IU) Health is the largest health system in the state of Indiana with 2708 total 41 
beds and over 118,000 hospital admissions annually and is partnered with the nation’s largest 42 
medical school, Indiana University School of Medicine.  Through close cooperation with our 43 
state government and examination of available epidemiological models, IU Health determined 44 
that a surge of patients affected by the novel coronavirus would encounter our health system in 45 
late March and within an anticipated peak in mid to late April.  Our program made the decision 46 
to stop all elective, non-urgent hip and knee arthroplasty surgery on 03/17/2020 and based on 47 
evolving data that became clear, the ambulatory aspect of patient care also ceased immediately.  48 
From a hip and knee arthroplasty perspective, appropriately triaging patients based on the extent 49 
of their clinical condition and acuity was paramount.   50 
 51 
Concurrently with the canceling of all elective surgeries and non-urgent patients in the 52 
ambulatory clinic setting, protocols were rapidly being developed to care for the more urgent 53 
needed orthopedic hip and knee arthroplasty patients, which included infections, fractures, and 54 
periprosthetic hip and knee fractures.  The Indiana University Hip and Knee Center at Saxony 55 
Hospital is part of a four hospital regional health network called the Indianapolis Suburban 56 
Region (ISR) and the administrative and clinical leadership immediately developed and enacted 57 
a plan to preserve PPE and hospital resources to support the appropriate deployment to the 58 
frontline caregivers that included emergency room physicians, pulmonologist, anesthesiologists, 59 
and critical care physicians and team members.  Simultaneously, PPE and equipment such as 60 
ventilators were moved from our orthopaedic focused hospital to the two larger hospitals in the 61 
ISR where COVID patients would be treated predominantly.   62 
 63 
From an outpatient perspective our ambulatory clinic made a number of significant changes that 64 
optimized patient safety as well as preservation of personal protective equipment.  Patients and 65 
staff members are required to use masks during every patient interaction and patients were seen 66 
in person only if the patient’s clinical condition was deemed urgent.  All exam rooms in their 67 
entirety were thoroughly cleaned with disinfectant between each and every patient.  In addition, 68 
like many other institutions in the United States and abroad, virtual interaction with existing and 69 
potential patients were initiated using HIPAA compliant software.  Virtual clinic visits were 70 
offered to follow-up and new patients, who consented to that form of clinical interaction. 71 
 72 
Unique to the outpatient surgery environment, the ambulatory surgery center facilities played a 73 
significant and vital role in terms of contributing resources to accommodate the surge of 74 
COVID-19 patients.  IU Health has a unique and collaborative partnership with Surgical Care 75 
Affiliates (SCA).   The partnership between the two entities encompasses 14 discrete ambulatory 76 
surgery centers (ASC) whose operations are run by Indiana University Health with 77 
administrative support from SCA.  The 14 IUH ASC’s perform approximately 75,000 outpatient 78 
surgeries annually and analogous to the main hospitals, the ASCs stopped all elective surgeries 79 
on March 17, 2020.  Supplies and staff from the ASCs were re-deployed into the hospitals to 80 
serve vital roles in the continued healthcare expansion to accept the medially ill patients within 81 
the COVID-19 surge. In fact, approximately 85% of extra supplies and equipment needed for the 82 
frontline providers in the four ISR hospitals were provided by the ASCs, clearly demonstrating 83 
the critical important role that the ASCs played and continue to play in the COVID pandemic 84 
response.  It is important to recognize the leadership role that ASCs play in the 2020 COVID-19 85 
pandemic.  SCA is one of many ambulatory surgery center entities in the US who play a vital 86 
role in healthcare delivery and were vital in rapidly deploying PPEs, ventilators, supplies, and 87 
staff to the various hospitals.  In our particular health system, three of the ambulatory surgery 88 
centers remained open for urgent ambulatory surgical care.  This further supported the healthcare 89 
resource conundrum, by performing urgent surgical care for less complex ambulatory procedures 90 
in the ASCs which allowed the more medically complex COVID-19 patients to have access to 91 
the inpatient hospital system.  Some guidelines and publications have been established regarding 92 
what constitutes an “urgent” procedure within and ASC or outpatient setting.[2]  It is generally 93 
accepted that an “urgent” procedure is a surgery that would increase the risk of permanent 94 
impairment or pain if not performed in a timely manner. 95 
 96 
 97 
The result of this rapid and effective system-wide planning, utilizing ASC resources in close 98 
partnership with our healthcare system, allowed adequate capacity to handle the COVID-19 99 
surge without any shortages of ventilators or ICU beds.  In addition, our health system provided 100 
the care for approximately 60% of the COVID-19 patients in the State of Indiana.  The social 101 
distancing efforts and state-mandated stay-at-home order was effective in “flattening” the curve 102 
of clinically relevant viral spread within our state and the subsequent burden placed on our health 103 
system (Figure 1).  As of April 16, 2020 the State of Indiana reported a flattening of the curve 104 
with 45% of ICU beds and 76% of ventilators across the state available.  Specifically, the IU 105 
Health system data revealed a general flattening of the overall inpatient census with a gradually 106 
smaller percentage requiring ICU status and/or ventilator support (Figure 1).  More 107 
encouragingly, the daily admissions into the IU Health system declined over the same time 108 
period after a peak in late March (Figure 2). 109 
 110 
POST COVID-19 OR “REVERSE SURGE.” 111 
At the time of this publication, there is much speculation about what the future of hip and knee 112 
arthroplasty outpatient surgery holds within the United States and abroad.  Nonetheless, the 113 
statistical models are of viral spread are rapidly evolving and becoming more accurate as we 114 
continue to understand the details of this novel coronavirus and its clinical sequelae COVID-19. 115 
Our hip and knee arthroplasty program is diligently developing protocols for keeping patients 116 
and health care workers safe upon the point in time that we resume elective hip and knee 117 
arthroplasties.  There are multiple factors that will need to be accounted for and the ASCs will 118 
likely play an expanded role in access to surgical care for patients with hip and knee arthritis. 119 
 120 
First are the protocols that must be developed in order to safely perform hip and knee 121 
arthroplasty in the COVID-19 era.  It is probable that every patient regardless of symptoms, will 122 
need to be tested for COVID-19 prior to elective surgery within a certain time prior to surgery.  123 
This will need to be embedded in the perioperative medical pathways which are typical for hip 124 
and knee arthroplasty programs.  It is also likely that all the surgical care teams and providers in 125 
the ambulatory surgery centers will need to self-monitor and document they are afebrile and do 126 
not have any COVID-19 type symptoms at a minimum before caring for the patients for the day 127 
and as rapid testing is further developed and accessible, may need to be done on a regular basis 128 
to the OR personnel since asymptomatic shed of the virus can occur with some frequency.  As 129 
testing and clinical information become more available and accurate, it is paramount that patient 130 
and health care worker safety is the number one priority.   Likely the most important component 131 
of successfully and safely performing elective total hip and knee surgery is accurate and 132 
accessible preoperative COVID-19 testing. 133 
 134 
It is important to understand that the specific COVID-19 testing is not a minimal requisite to 135 
performing total hip and knee arthroplasty in patients with the expectations for same day 136 
discharge.  Over the past few years, there has been substantial research that provides guidance on 137 
safe patients selection, optimal pathways and protocols and the essential elements for 138 
successfully and safely performing hip and knee arthroplasty in the outpatient and/or ASC 139 
environment,[3-5] along with recommendations to avoid the most common pitfalls and barriers 140 
to discharge such as postoperative urinary retention.[6]  It is mandatory that surgeons, 141 
institutions and programs develop and maintain appropriate outpatient arthroplasty protocols, in 142 
addition to the additional COVID-19 testing.[4]   143 
 144 
There is a definite trend in United States over the past few years in performing a greater 145 
percentage of total hip and knee arthroplasty patients in the outpatient environment with same 146 
day discharge to home.  Recent developments include removing total knee arthroplasty off the 147 
inpatient only list in 2018, followed by removing total hip arthroplasty off the inpatient only list 148 
and allowing total knee arthroplasty to be performed in Medicare beneficiaries in a freestanding 149 
ASC January 2020.  There have been substantial advantages purported for performing hip and 150 
knee arthroplasty in the outpatient setting that have included improved patient satisfaction,[7] 151 
less complications and minimizing the impatient hospital burden.  It has been further shown that 152 
outpatient total knee arthroplasty is feasible in the Medicare population.[8]  The latter benefits 153 
has the potential to becoming increasingly important in the post- COVID-19 era.  From a health 154 
care resource perspective, the COVID-19 pandemic has highlighted our national health care 155 
infrastructure in some geographies may not have capacity to handle large numbers of medically 156 
ill patients without compromising the ability to provide elective surgical care, such as hip and 157 
knee arthroplasty.  The ASCs can provide a great benefit to the health care system by expanding 158 
their capacity to accept hip and knee arthroplasty patients who meet medical and surgical criteria 159 
to safely discharge the same day.  This conserves bed capacity for the larger inpatient hospitals 160 
to safely accept and treat medically ill patients, like those with respiratory illness from COVID-161 
19.  This impact with not only be prevalent in the short term, but will also be lasting as it has 162 
become known that COVID-19 will continue in our society for the next few years until larger, 163 
broad based immunity is enacted through a vaccine and consistent exposure to the virus by the 164 
population.  ASC infrastructure will face a challenge in terms of capacity to handle these larger 165 
and more complex surgical procedures such as hip and knee arthroplasty.  While COVID-19 has 166 
accelerated the push for hip and knee arthroplasty within the outpatient setting, ASC’s have been 167 
addressing the facility limitations over the past few years due to external forces lead by the 168 
government and CMS (Center for Medicare and Medicaid Services).   Now that Medicare 169 
beneficiaries able to undergo knee arthroplasty in freestanding ASCs, these facilities have been 170 
attempting to address their subsequent shortcomings that include limited capacity in terms of 171 
available square footage, inadequate central sterile processing capacity for larger numbers of 172 
trays and in some cases, lack of qualified staff who are capable of caring for hip and knee 173 
arthroplasty patients.   Compared to the traditional smaller surgeries performed in ASCs, total 174 
hip and knee arthroplasty can be associated with more blood loss, more soft tissue trauma and 175 
unique perioperative issues in the first few hours after surgery that may challenge the ASC staff.  176 
However, with proper training, experience and mentoring from others with experience 177 
discharging hip and knee arthroplasty patients the same day of surgery, the ASC staff can 178 
become proficient and capable in caring for these patients.   179 
 180 
Finally, patient demand will almost certainly fuel an increasing surgical volume of hip and knee 181 
arthroplasty into the ASC facilities.  While traditionally only about half of patients were aware 182 
that outpatient total joint arthroplasty was an option as reported in one recent study,[9] the 183 
increased patient demand in the post-COVID-19 era will be primarily driven by the lingering 184 
fear by patients and their families that hospitals are the primary societal location of the highly 185 
contagious and potentially lethal SARS-CoV-2 virus.  This fear has spawned from the data (and 186 
excessive media coverage) demonstrating this particular virus is highly contagious and can affect 187 
even well-protected health care workers and can be spread in a high percentage of asymptomatic 188 
individuals and in some cases, can prove fatal by mechanisms not currently understood. 189 
 190 
CONCLUSION 191 
In summary, the ambulatory and outpatient setting will not be exempt from the significant 192 
change and paradigm change occurring as a result of the COVID-19 pandemic.  ASCs and 193 
hospitals will have a unique set of challenges and also a unique opportunity to be the beneficiary 194 
of an accelerated push for the hip and knee arthroplasty to be performed in the outpatient setting.  195 
Subsequently, there should be a significant effort and commitment to putting together pathways, 196 
protocols, resources and facilities that can safely care for the hip and knee arthroplasty patient 197 
with a plan for same day discharge, in order to spare and conserve healthcare resource 198 
consumption.  From our own personal experience and implementation of rapid redeployment of 199 
resources, staff and supplies with a close partnership and collaboration with our ASCs, Indiana 200 
University Health was able to successfully treat all of the COVID-19 patients without 201 
overburdening the system and we anticipate also being able to treat these patients safely going 202 
forward with a renewed emphasis on early discharge, both from the ambulatory surgery center as 203 
well as from within the hospital itself. 204 
 205 
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Figure Legend: 
Figure 1: Inpatient and observation COVID-19 census data for a large academic health system 
over time demonstrating the flattening curve phenomenon. 
Figure 2: COVID-19 inpatient and observation admissions by arrival dates at a large academic 
health system, demonstrating the steady decline of admissions from late May until current. 
